ACRO Biomedical (6748.TWO) Earnings Analysis
ACRO Biomedical (6748.TWO) has no confirmed upcoming earnings date. Trailing P/E -126.81.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6748.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 6748.TWO. This page updates as the calendar is published.
6748.TWO earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
6748.TWO valuation and analyst view
| Trailing P/E | -126.81 |
|---|---|
| Trailing EPS | -1.66477 TWD |
| Price / book | 11.67 |
| Dividend yield | 0.00% |
| Market cap | 15.74B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is ACRO Biomedical (6748.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 6748.TWO. This page updates as the calendar is published.
What is 6748.TWO's current P/E ratio and EPS?
6748.TWO trades at a trailing P/E of -126.81 on trailing EPS of -1.6647667886072641 TWD.
What do analysts rate 6748.TWO?
6748.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.